CN104561285A - Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone - Google Patents

Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone Download PDF

Info

Publication number
CN104561285A
CN104561285A CN201410828052.8A CN201410828052A CN104561285A CN 104561285 A CN104561285 A CN 104561285A CN 201410828052 A CN201410828052 A CN 201410828052A CN 104561285 A CN104561285 A CN 104561285A
Authority
CN
China
Prior art keywords
seq
nucleic acid
acid fragment
amplification
sequencing primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410828052.8A
Other languages
Chinese (zh)
Inventor
陈必成
周蒙滔
张纯武
徐慧英
王张阳
朱哲慧
叶文乐
褚光宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of Wenzhou Medical University
Original Assignee
First Affiliated Hospital of Wenzhou Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of Wenzhou Medical University filed Critical First Affiliated Hospital of Wenzhou Medical University
Priority to CN201410828052.8A priority Critical patent/CN104561285A/en
Publication of CN104561285A publication Critical patent/CN104561285A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses an amplification and sequencing primer and a reagent kit for single nucleotide polymorphism detection of a microRNA-146a (micro ribonucleic acid-146a) gene and in a prozone. The reagent kit comprises reaction liquid A for PCR (polymerase chain reaction) amplification, reaction tubes coating primers and primers S1, S2, S3 and S4 for sequencing. The primer can amplify segments where an SNP (single nucleotide polymorphism) in human miR-146a (micro ribonucleic acid-146a) and four SNPs in the gene prozone are located under the same reaction condition at one time, and then sequencing is carried out by the sequencing primers. The primers are directly coated in the reaction tubes to avoid difficulty in primer configuration. The kit can be used for detection of a clinical sample and provide more biological information of the polymorphism of miR-146a.

Description

The amplification detected for single nucleotide polymorphism in microRNA-146a gene and proparea and sequencing primer and test kit thereof
Technical field
The present invention relates to the molecular biology method based on polymerase chain reaction (PCR) and DNA sequencing technology, particularly relate to a kind of amplification of detecting for 5 single nucleotide polymorphism (SNP) in microRNA (miR) 146a gene and gene proparea thereof and sequencing primer and test kit thereof.
Background technology
Microrna (microRNA, miR) is the strand non-coding RNA that endogenic length is about 19-21 Nucleotide, can regulate the expression of encoding gene.These RNA molecule are with the level of complicated mode Function protein instead of the expression suppressing target gene completely.Although these effects may be very slight, there is a large amount of genes to regulate and control by miR, show that they are very important Molecular regulators.Everybody admits miR and plays an important role in the biological action of many complexity at present, such as fetal development, tissue identification, propagation, differentiation, apoptosis, signal path, metabolism, tumour and virus infection etc.Recently also find that miR is relevant with autoimmune disorder.In numerous miR, miR-146a is study hotspot.
The biosynthetic process of this miRNA mainly comprises that miR-96 gene is transcribed, precursor RNA synthesis in core, core export, endochylema processing and assembling etc.MiR-146a rs2910164G/C allelotrope is positioned at the 60th Nucleotide of pre-miR-146a, namely on miR-146a.Allele C can cause the mispairing of pre-miR-146a hairpin structure, make △ G reduce to-40.3kcal/mol from-43.1kcal/mol, thus reduce the efficiency that the stability of pri-miR, the efficiency of pri-miR formation pre-miR or pre-miR form miR-146a.And rs2431697, rs57095329, rs6864584, rs2277920 are positioned at the intergenic region before miR-146a gene, the expression efficiency of miR-146a may be affected.At present, what these single nucleotide polymorphism researchs were more is and disease-related Journal of Sex Research comprise tumour, silver bits property sacroiliitis, multiple sclerosis, tuberculosis, systemic lupus erythematous and rheumatoid arthritis etc.
Summary of the invention
The object of the invention is to overcome in existing molecular diagnostic techniques detect the SNP type that miR-146a will comprise many, detect incomplete defect, there is provided a set of optimization primer for pcr amplification and order-checking, disposablely under the same conditions can carry out 4 PCR, smoothly the gene fragment comprising miR-146a be increased and checked order.
The present invention's second object is to provide a kind of this primer supporting and carries out the specific PCR response procedures that in miR-146a gene and front region sequence, 5 SNP detect, and reaches the object of rapid amplifying.
The present invention's the 3rd object is to provide a kind ofly carries out SNP in miR-146a gene and front region sequence thereof to clinical samples and carries out the fluorescent PCR amplification kit of sequential analysis.
Technical scheme of the present invention is summarized as follows:
The amplification detected for single nucleotide polymorphism in microRNA-146a gene and proparea and sequencing primer, comprising containing the amplification of rs2431697 nucleic acid fragment and sequencing primer is SEQ ID NO.1 and SEQ ID NO.2, be SEQ ID NO.3 and SEQ ID NO.4 containing the amplification of rs57095329 and rs6864584 nucleic acid fragment and sequencing primer, being SEQ ID NO.5 and SEQ ID NO.6 containing the amplification of rs2277920 nucleic acid fragment and sequencing primer, is SEQ ID NO.7 and SEQ ID NO.8 containing the amplification of rs2910164 nucleic acid fragment and sequencing primer.
Supporting amplification comprises the PCR reaction of rs2431697, rs57095329, rs6864584, rs2277920, rs2910164 nucleic acid fragment, is after 95 DEG C of denaturation 3min, 94 DEG C of sex change 15s, 56 DEG C of annealing 15s, 72 DEG C extend 35s, carry out 35 circulations, be then kept at 25 DEG C; Timely taking-up is checked order.
A kind of amplification for single nucleotide polymorphism detection in microRNA-146a gene and proparea and sequencing kit:
Reagent A: be made up of 2mL damping fluid, comprise green I dyestuff, 0.2mM dNTPs (comprising dATP, dCTP, dGTP, dTTP), 80mM Tris-HCl, 80mM KCl, 40mM (NH4) 2SO4,6mM MgSO4,100U Taq archaeal dna polymerase;
Reagent S1: by for the sequencing primer 30 μ L aqueous solution containing rs2431697 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.2;
Reagent S2: by for the sequencing primer 30 μ L aqueous solution containing rs57095329 and rs6864584 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.4;
Reagent S3: by for the sequencing primer 30 μ L aqueous solution containing rs2277920 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.6;
Reagent S4: by for the sequencing primer 30 μ L aqueous solution containing rs2910164 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.8;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing for the amplimer mixing composition containing rs2431697 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.1 and 1.5 × 10 -2nmol SEQ ID NO.2;
No. two reaction tubess: containing for the amplimer mixing composition containing rs57095329 and rs6864584 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.3 and 1.5 × 10 -2nmol SEQ ID NO.4;
No. three reaction tubess: containing for the amplimer mixing composition containing rs2277920 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.5 and 1.5 × 10 -2nmol SEQ ID NO.6;
No. four reaction tubess: containing for the amplimer mixing composition of A containing rs2910164 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.7 and 1.5 × 10 -2nmol SEQ ID NO.8;
No. five reaction tubess: same number pipe;
No. six reaction tubess: with No. two pipes;
No. seven reaction tubess: with No. three pipes;
No. eight reaction tubess: with No. four pipes.
Advantage of the present invention:
1) provide and a set ofly carry out the primer of fast PCR and the sequencing primer of optimization, the sequence of all 5 SNP of all miR-146a of disposable amplification is used for follow-up order-checking; 2) be with fluorescence dye in reaction system, directly can observe amplification by quantitative fluorescent PCR, the inconvenience avoiding electrophoresis to bring and pollution; 3) primer direct coated is in reaction tubes, avoids primer to configure difficulty.By optimization experiment reaction system and reaction conditions, form simple, quick, sensitive, special detection kit, can be used for the detection to clinical samples, can man power and material be reduced, more experiment information is provided.
Accompanying drawing explanation
Fig. 1 is the SNP distribution in miR-146a gene and proparea.
Fig. 2 behaves the sequencing result of SNP in miR-146a gene and proparea.
Embodiment
In following embodiment, method therefor is ordinary method if no special instructions.
Amplification of the present invention and sequencing primer nucleotides sequence are classified as:
SEQ ID NO.1 5’-attatgattggcaaatggaagg-3’
SEQ ID NO.2 5’-tttggctggatggaggat-3’
SEQ ID NO.3 5’-attgggcagccgataaag-3’
SEQ ID NO.4 5’-ctcctcgttgtgctactgtctc-3’
SEQ ID NO.5 5’-ggagacagtagcacaacgag-3’
SEQ ID NO.6 5’-tagccatagtcttccaaccc-3’
SEQ ID NO.7 5’-cccacatcagccttccag-3’
SEQ ID NO.8 5’-ccaggtcctcaagcccac-3’
Embodiment 1
A set of for the amplification of SNP detection in people miR-146a gene and proparea and the Auele Specific Primer of order-checking, comprising containing the amplification of rs2431697 nucleic acid fragment and sequencing primer is SEQ ID NO.1 and SEQ ID NO.2, be SEQ ID NO.3 and SEQ ID NO.4 containing the amplification of rs57095329 and rs6864584 nucleic acid fragment and sequencing primer, being SEQ ID NO.5 and SEQ ID NO.6 containing the amplification of rs2277920 nucleic acid fragment and sequencing primer, is SEQ ID NO.7 and SEQ ID NO.8 containing the amplification of rs2910164 nucleic acid fragment and sequencing primer.
Embodiment 2
For in miR-146a gene and front region sequence thereof SNP detect amplification and a sequencing kit, be made up of following reagent:
Reagent A: be made up of 2mL damping fluid, comprise green I dyestuff, 0.2mM dNTPs (comprising dATP, dCTP, dGTP, dTTP), 80mM Tris-HCl, 80mM KCl, 40mM (NH4) 2SO4,6mM MgSO4,100U Taq archaeal dna polymerase;
Reagent S1: by for the sequencing primer 30 μ L aqueous solution containing rs2431697 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.2;
Reagent S2: by for the sequencing primer 30 μ L aqueous solution containing rs57095329 and rs6864584 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.4;
Reagent S3: by for the sequencing primer 30 μ L aqueous solution containing rs2277920 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.6;
Reagent S4: by for the sequencing primer 30 μ L aqueous solution containing rs2910164 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.8;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing for the amplimer mixing composition containing rs2431697 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.1 and 1.5 × 10 -2nmol SEQ ID NO.2;
No. two reaction tubess: containing for the amplimer mixing composition containing rs57095329 and rs6864584 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.3 and 1.5 × 10 -2nmol SEQ ID NO.4;
No. three reaction tubess: containing for the amplimer mixing composition containing rs2277920 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.5 and 1.5 × 10 -2nmol SEQ ID NO.6;
No. four reaction tubess: containing for the amplimer mixing composition of A containing rs2910164 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.7 and 1.5 × 10 -2nmol SEQ ID NO.8;
No. five reaction tubess: same number pipe;
No. six reaction tubess: with No. two pipes;
No. seven reaction tubess: with No. three pipes;
No. eight reaction tubess: with No. four pipes.
Embodiment 3
All exons of real-time fluorescence quantitative PCR (the real-time FQ PCR) androgen receptor that increases are carried out with test kit of the present invention.First, sample number empirically calculates the requirement of each reagent, and experimental procedure is as follows:
1. amplification reaction solution configuration: configure reaction solution (1 is detected sample) in order, add water 120 μ L, reagent A 150 μ L, DNA sample 30 μ L, totally 300 μ L; Mixing.
2. each pipe is sequentially added into the amplification reaction solution of 25 μ L, builds lid.
3. the PCR program empirically designed increases: be after 95 DEG C of denaturation 3min, 94 DEG C of sex change 1min, 56 DEG C of annealing 1mins, and 72 DEG C extend 35s, and extended peroid obtains fluorescent value, carries out 35 circulations, is finally kept at 25 DEG C; Timely taking-up is checked order.
4. fluorescent value is 22-28 circulation take-off, and specific amplification is thought in the take-off simultaneously of each group, sees Fig. 1.
Embodiment 4
The primer supporting with test kit of the present invention checks order:
To detect 1 sample, 4 PCR check order as example is carried out.
1.PCR product purification (ExoI/SAP method):
1.1 preparation purification system: exonuclease 1 (ExoI) 3 μ L+ shrimp solution enzyme (SAP) 6 μ L+ water 3 μ L, totally 12 μ L, mixing.
The 1.2 purification system 2 μ L getting preparation mix (4) with each amplified production 8 μ L totally, add in another blank Sptting plate.
Sptting plate is placed on more than PCR instrument by 1.3,37 DEG C of 30min, 80 DEG C of 20min, can preserve about 1 week in 4 DEG C of refrigerators.
2. sequencing reaction:
In 2.110 μ L PCR purified products, every hole adds 20 μ L water, fully after mixing, centrifugal.
2.2 preparation sequencing reaction systems: get 4.8 μ L BDT Ready Reaction Premix (2.5 ×) and add 21.6 μ L BDT damping fluid (5 ×) and add 69.6 μ L Deionised water and mix.Get the above-mentioned mixed solution of 8 μ L each 1 μ L fully mixes with S1, S2, S3, S4 respectively at every turn, centrifugal fast.
2.3 every hole PCR primer diluents get 1 μ L to (4 hole) in reacting hole, and every hole adds 9 μ L sequencing reaction mixed solutions, mixing, centrifugal fast.
Sptting plate is placed in PCR instrument by 2.4, and PCR sealing load pad is put at Sptting plate top, to prevent liquid evaporation, shuts PCR instrument, runs sequencing reaction: after 96 DEG C of 10s, carrying out 25 circulations is 96 DEG C of 10s, 50 DEG C of 10s, 60 DEG C of 2min, finally preserves 15 DEG C and takes out.
3. sequencing reaction product purification:
1 μ LEDTA, 1 μ L NaAc and 25 μ L dehydrated alcohols are added, fully concussion mixing 30s in 3.1 sequencing reaction hole, every holes.Room temperature places the centrifugal 30min. of 15min, 3000rpm
3.2 are inverted Sptting plate, adjusting rotary speed, the centrifugal 1min of 500rpm
50 μ L 70% ethanol are added, the centrifugal 10min of 3000rpm in 3.3 every hole sequencing reaction products.
3.4 are inverted Sptting plate, the centrifugal 1min of 500rpm.
3.5 room temperature lucifuges leave standstill 30min, fully ethanol in volatilization plate.
Add methane amide 10 μ L, shrouding in 3.6 every holes, be placed on more than PCR 95 DEG C of 2min, put into rapidly-20 DEG C of refrigerator cooling 3-5min.
4. sequenator reads plate detection: use ABI3500 sequenator to detect sequencing result.The sequencing result software that makes to check order accordingly carries out data analysis, sees Fig. 2.
Embodiment 5
Sequencing result and miR-146a gene and proparea sequence criteria sequence thereof are compared:
1. sequencing result carry out observing whether have bimodal, prompting heterozygote;
2. do not find bimodal, standard order-checking and sequencing result Input Software being compared, is homozygote;
3. pair position different from standard sequence is analyzed, and is above-mentionedly decided to be new catastrophe point as non-.
Sequence table
 
<110> The First Affiliated Hospital of Wenzhou Medical University
 
<120> is used for amplification that in microRNA-146a gene and proparea, single nucleotide polymorphism detects and sequencing primer and test kit thereof
 
<160> 8
 
<170> PatentIn Version 2.1
 
<210> 1
<211> 22
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(22)
 
<400> 1
attatgattg gcaaatggaa gg 22
 
<210> 2
<211> 18
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(18)
 
<400> 2
tttggctgga tggaggat 18
 
<210> 3
<211> 18
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(18)
 
<400> 3
attgggcagc cgataaag 18
 
<210> 4
<211> 22
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(22)
 
<400> 4
ctcctcgttg tgctactgtc tc 22
 
<210> 5
<211> 20
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(20)
 
<400> 5
ggagacagta gcacaacgag 20
 
<210> 6
<211> 20
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(20)
 
<400> 6
tagccatagt cttccaaccc 20
 
<210> 7
<211> 18
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(18)
 
<400> 7
cccacatcag ccttccag 18
 
<210> 8
<211> 18
<212> DNA
<213> artificial sequence
 
<220>
<221> prim_bind
<222> (1)...(18)
 
<400> 8
ccaggtcctc aagcccac 18
 
 

Claims (2)

1. the amplification for single nucleotide polymorphism detection in microRNA-146a gene and proparea and sequencing primer, it is characterized in that on the basis of optimize PCR design of primers, disposablely under the same conditions can carry out 4 polymerase chain reactions, complete the amplification of the nucleic acid fragment containing all 5 SNP; And by sequencing primer, order-checking difference is carried out to 5 SNP, comprising containing the amplification of rs2431697 nucleic acid fragment and sequencing primer is SEQ ID NO.1 and SEQ ID NO.2, be SEQ ID NO.3 and SEQ ID NO.4 containing the amplification of rs57095329 and rs6864584 nucleic acid fragment and sequencing primer, being SEQ ID NO.5 and SEQ ID NO.6 containing the amplification of rs2277920 nucleic acid fragment and sequencing primer, is SEQ ID NO.7 and SEQ ID NO.8 containing the amplification of rs2910164 nucleic acid fragment and sequencing primer.
2., for amplification and the sequencing kit of single nucleotide polymorphism detection in microRNA-146a gene and proparea, it is characterized in that being made up of following reagent:
Reagent A: be made up of 2mL damping fluid, comprises 2 × SYBR Green I dyestuff, 0.2mM dNTPs, 80mM Tris-HCl, 80mM KCl, 40mM (NH4) 2SO4,6mM MgSO4,100U Taq archaeal dna polymerase;
Reagent S1: by for the sequencing primer 30 μ L aqueous solution containing rs2431697 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.2;
Reagent S2: by for the sequencing primer 30 μ L aqueous solution containing rs57095329 and rs6864584 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.4;
Reagent S3: by for the sequencing primer 30 μ L aqueous solution containing rs2277920 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.6;
Reagent S4: by for the sequencing primer 30 μ L aqueous solution containing rs2910164 nucleic acid fragment, comprise 4 μMs of SEQ ID NO.8;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing for the amplimer mixing composition containing rs2431697 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.1 and 1.5 × 10 -2nmol SEQ ID NO.2;
No. two reaction tubess: containing for the amplimer mixing composition containing rs57095329 and rs6864584 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.3 and 1.5 × 10 -2nmol SEQ ID NO.4;
No. three reaction tubess: containing for the amplimer mixing composition containing rs2277920 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.5 and 1.5 × 10 -2nmol SEQ ID NO.6;
No. four reaction tubess: containing for the amplimer mixing composition of A containing rs2910164 nucleic acid fragment, comprise 1.5 × 10 -2nmol SEQ ID NO.7 and 1.5 × 10 -2nmol SEQ ID NO.8;
No. five reaction tubess: same number pipe;
No. six reaction tubess: with No. two pipes;
No. seven reaction tubess: with No. three pipes;
No. eight reaction tubess: with No. four pipes.
CN201410828052.8A 2014-12-26 2014-12-26 Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone Pending CN104561285A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410828052.8A CN104561285A (en) 2014-12-26 2014-12-26 Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410828052.8A CN104561285A (en) 2014-12-26 2014-12-26 Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone

Publications (1)

Publication Number Publication Date
CN104561285A true CN104561285A (en) 2015-04-29

Family

ID=53078359

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410828052.8A Pending CN104561285A (en) 2014-12-26 2014-12-26 Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone

Country Status (1)

Country Link
CN (1) CN104561285A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106636307A (en) * 2015-11-02 2017-05-10 广东医学院 Application of miRNA-146a mutant in preparing test strip for early screening and rapid diagnosis of cervical cancer
CN109337960A (en) * 2018-11-14 2019-02-15 昆明新开源暾秀生物科技有限公司 A kind of diagnostic kit and its detection method of epilepsy in childhood

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIN WEI ET AL.: "MicroRNA-146a and Ets-1 Gene Polymorphisms Are Associated with Pediatric Uveitis", 《PLOS ONE》 *
SE LOFGREN ET AL.: "Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene", 《GENES AND IMMUNITY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106636307A (en) * 2015-11-02 2017-05-10 广东医学院 Application of miRNA-146a mutant in preparing test strip for early screening and rapid diagnosis of cervical cancer
CN109337960A (en) * 2018-11-14 2019-02-15 昆明新开源暾秀生物科技有限公司 A kind of diagnostic kit and its detection method of epilepsy in childhood

Similar Documents

Publication Publication Date Title
Forero et al. qPCR-based methods for expression analysis of miRNAs
US10344321B2 (en) Method for identification and quantification of nucleic acid expression, splice variant, translocation, copy number, or methylation changes
EP2419538B1 (en) Methods and compositions to detect and differentiate small rnas in rna maturation pathway
CN107488710A (en) A kind of purposes of Cas albumen and the detection method and kit of target nucleic acids molecule
Li et al. A strategy for co-analysis of microRNAs and DNA
CN113604564A (en) Method for detecting exosome-associated microRNA (ribonucleic acid) molecules
US11761037B1 (en) Probe and method of enriching target region applicable to high-throughput sequencing using the same
CN102154505A (en) Method and primers for detecting mi ribonucleic acid (miRNA) and application of method
Varkonyi-Gasic Stem-loop qRT-PCR for the detection of plant microRNAs
CN108251522A (en) Human MTHFR and MTRR gene detection kit and application thereof
Stiefel et al. miRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering
Jacobsen et al. Profiling microRNAs by real-time PCR
CN101082060A (en) New micro ribonucleic acid quantitative PCR (polymerase chain reaction) detection method
CN101805790A (en) Method for simultaneously detecting polymorphism of 32 SNP loci on 24 sports-related genes
Zhou et al. Sensitive and specific microRNA detection by RNA dependent DNA ligation and rolling circle optical signal amplification
CN102399862A (en) Methylated DNA detection method based on melting curve
Wang et al. Ultrasensitive multiplexed detection of miRNA targets of interest based on encoding probe extension in improved cDNA library
CN102399861A (en) Methylated DNA (Deoxyribonucleic Acid) detection method based on endonuclease digestion
CN104561285A (en) Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone
Tan et al. Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells
Takada et al. Profiling of microRNA expression by mRAP
Liu MicroRNA expression analysis: next-generation sequencing
CN107988334B (en) Method for SNP typing by direct PCR of oral swab
CN110468179A (en) The method of selective amplification nucleic acid sequence
Castoldi et al. 22 Expression Profiling of MicroRNAs by Quantitative Real-Time PCR

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150429